Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00532740 · ClinicalTrials.gov registry record
Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00532740: Completed study, sponsored by Northwestern University.
NCT00532740 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00532740 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery. PURPOSE: This phase II trial is studying how well radiolabeled glass beads work in treating patients with metastatic liver cancer that cannot be removed by surgery.
Interventions
- RADIATION Yttrium Y 90 glass microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2004-12 |
| Est. Completion | 2022-03-16 |
What the finished NCT00532740 record still lists
NCT00532740 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Yttrium Y 90 glass microspheres is the first listed.
NCT00532740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00532740 about?
NCT00532740 is a clinical study titled "Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery". RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery. PURPOSE: This phase II trial is studying how we...
What is the current status of trial NCT00532740?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2004-12. Estimated completion is 2022-03-16.
What interventions are being tested in trial NCT00532740?
The interventions under investigation include: Yttrium Y 90 glass microspheres (RADIATION).
Who is sponsoring clinical trial NCT00532740?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia